These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration. Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674 [TBL] [Abstract][Full Text] [Related]
3. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia. Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806 [TBL] [Abstract][Full Text] [Related]
4. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers. Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders. Bourbouli M; Rentzos M; Bougea A; Zouvelou V; Constantinides VC; Zaganas I; Evdokimidis I; Kapaki E; Paraskevas GP Dement Geriatr Cogn Disord; 2017; 44(3-4):144-152. PubMed ID: 28848086 [TBL] [Abstract][Full Text] [Related]
6. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576 [TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics. Kojima Y; Kasai T; Noto YI; Ohmichi T; Tatebe H; Kitaoji T; Tsuji Y; Kitani-Morii F; Shinomoto M; Allsop D; Teramukai S; Mizuno T; Tokuda T PLoS One; 2021; 16(11):e0260323. PubMed ID: 34843548 [TBL] [Abstract][Full Text] [Related]
9. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases. Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214 [TBL] [Abstract][Full Text] [Related]
10. Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia. Takeuchi R; Toyoshima Y; Tada M; Tanaka H; Shimizu H; Shiga A; Miura T; Aoki K; Aikawa A; Ishizawa S; Ikeuchi T; Nishizawa M; Kakita A; Takahashi H Brain Pathol; 2016 Jan; 26(1):82-94. PubMed ID: 25787090 [TBL] [Abstract][Full Text] [Related]
11. Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy. Behrouzi R; Liu X; Wu D; Robinson AC; Tanaguchi-Watanabe S; Rollinson S; Shi J; Tian J; Hamdalla HH; Ealing J; Richardson A; Jones M; Pickering-Brown S; Davidson YS; Strong MJ; Hasegawa M; Snowden JS; Mann DM Acta Neuropathol Commun; 2016 Mar; 4():33. PubMed ID: 27036121 [TBL] [Abstract][Full Text] [Related]
12. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281 [TBL] [Abstract][Full Text] [Related]
13. Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908 [TBL] [Abstract][Full Text] [Related]
14. Molecular pathology markers of FTD and ALS in blood extracellular vesicles. Nat Med; 2024 Jun; 30(6):1545-1546. PubMed ID: 38890532 [No Abstract] [Full Text] [Related]
15. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum. Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS; JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712 [TBL] [Abstract][Full Text] [Related]
16. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum. Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485 [TBL] [Abstract][Full Text] [Related]
17. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis. van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C; Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419 [TBL] [Abstract][Full Text] [Related]
18. Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Ferraro PM; Jester C; Olm CA; Placek K; Agosta F; Elman L; McCluskey L; Irwin DJ; Detre JA; Filippi M; Grossman M; McMillan CT Neurobiol Aging; 2018 Aug; 68():85-92. PubMed ID: 29751289 [TBL] [Abstract][Full Text] [Related]
19. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP. Llibre-Guerra JJ; Lee SE; Suemoto CK; Ehrenberg AJ; Kovacs GG; Karydas A; Staffaroni A; Franca Resende EP; Kim EJ; Hwang JH; Ramos EM; Wojta KJ; Pasquini L; Pang SY; Spina S; Allen IE; Kramer J; Miller BL; Seeley WW; Grinberg LT Brain Pathol; 2021 Mar; 31(2):267-282. PubMed ID: 33314436 [TBL] [Abstract][Full Text] [Related]
20. Progressive supranuclear palsy in a family with TDP-43 pathology. Kertesz A; Finger E; Murrell J; Chertkow H; Ang LC; Baker M; Ravenscroft T; Rademakers R; Munoz DG Neurocase; 2015; 21(2):178-84. PubMed ID: 24479957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]